You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Central Diabetes Insipidus

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Central Diabetes Insipidus (cDI) Trial in Basel (Intranasal OXT, Placebo nasal spray)

Not yet recruiting
  • Central Diabetes Insipidus (cDI)
  • Intranasal OXT
  • Placebo nasal spray
  • Basel, Switzerland
    University Hospital Basel, Department of Endocrinology, Diabetes
Sep 6, 2023

Central Diabetes Insipidus Trial in Boston (Oxytocin nasal spray)

Not yet recruiting
  • Central Diabetes Insipidus
  • Oxytocin nasal spray
  • Boston, Massachusetts
    Massachusetts General Hospital, Neuroendocrine Unit
Apr 28, 2022

Oxytocin Deficiency, Hypopituitarism, Hypothalamic Obesity Trial in Barcelona (Melatonin)

Not yet recruiting
  • Oxytocin Deficiency
  • +5 more
  • Melatonin
  • Barcelona, Spain
    Hospital de la Santa Creu i Sant Pau
Mar 31, 2022

Hypopituitarism, Central Diabetes Insipidus, Panhypopituitarism Trial in Barcelona (Experimental: CRH administration, Control:

Recruiting
  • Hypopituitarism
  • +7 more
  • Experimental: CRH administration
  • Control: Placebo administration
  • Barcelona, Spain
    Hospital de la Santa Creu i Sant Pau
Mar 18, 2022

Hypopituitarism, Central Diabetes Insipidus, Panhypopituitarism Trial in Barcelona (Experimental: GLP1-RA (exenatide)

Recruiting
  • Hypopituitarism
  • +7 more
  • Experimental: GLP1-RA (exenatide) administration
  • Control: Placebo administration
  • Barcelona, Spain
    Hospital de la Santa Creu i Sant Pau
Mar 18, 2022

Diabetes Insipidus, Polydipsia, Primary Trial in Worldwide (Arginine infusion, Hypertonic saline infusion)

Completed
  • Diabetes Insipidus
  • Polydipsia, Primary
  • Arginine infusion
  • Hypertonic saline infusion
  • Belo Horizonte, Brazil
  • +6 more
Nov 30, 2022

Diabetes Insipidus Trial in Basel (study intervention: 3,4-methylenedioxymethamphetamine (MDMA, ecstasy), Control intervention:

Completed
  • Diabetes Insipidus
  • study intervention: 3,4-methylenedioxymethamphetamine (MDMA, ecstasy)
  • Control intervention: Placebo
  • Basel, Switzerland
    University Hospital Basel, Endocrinology, Diabetes and Metabolis
Apr 12, 2022

Diabetes Insipidus Trial in Basel (Glucagon, Placebo)

Completed
  • Diabetes Insipidus
  • Glucagon
  • Placebo
  • Basel, Switzerland
    Divison of Endocrinology, Diabetes and Metabolism,University Hos
May 18, 2022

Bipolar Disorder Trial (Anhydrous Amiloride Hydrochloride, Placebo)

Not yet recruiting
  • Bipolar Disorder
  • Anhydrous Amiloride Hydrochloride
  • Placebo
  • (no location specified)
May 16, 2022

Lithium Treated Patients

Not yet recruiting
  • Lithium Toxicities
  • +4 more
  • Deamino Arginine Vasopressin (dDAVP)
  • Nijmegen, Gelderland, Netherlands
    Canisius Wilhelmina Ziekenhuis
Mar 23, 2022

Seoul National University Pituitary Disease Cohort Study

Recruiting
  • Pituitary Disease
  • +7 more
  • Dynamic hormone study and Magnetic resonance imaging
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Mar 17, 2020

Autosomal Dominant Polycystic Kidney Disease, Nephrogenic Diabetes Insipidus, Acquired Nephrogenic Diabetes Insipidus Trial in

Recruiting
  • Autosomal Dominant Polycystic Kidney Disease
  • +3 more
  • Rochester, Minnesota
    Mayo Clinic Rochester
Feb 14, 2022

Nephrogenic Diabetes Insipidus During Prolonged Sevoflurane

Recruiting
  • Nephrogenic Diabetes Insipidus
  • Jette, Brussel, Belgium
    UZ Brussel
Nov 3, 2021

Arginine Vasopressin Deficiency, Primary Polydipsia Trial in Basel (Urea, Placebo)

Recruiting
  • Arginine Vasopressin Deficiency
  • Primary Polydipsia
  • Urea
  • Placebo
  • Basel, Switzerland
    University Hospital Basel
Jun 6, 2023

Pituitary Adenoma, Pituitary Tumor, Diabetes Insipidus Cranial Type Trial in Leiden (Micro-electrode measurement)

Recruiting
  • Pituitary Adenoma
  • +3 more
  • Micro-electrode measurement
  • Leiden, Netherlands
    Leiden University Medical Center
Apr 13, 2022

Central Insulin Resistance, Diabetes, Type 2, PreDiabetes Trial (Human nasal insulin, Placebo)

Not yet recruiting
  • Central Insulin Resistance
  • +2 more
  • Human nasal insulin
  • Placebo
  • (no location specified)
May 12, 2023

Type 2 Diabetes, Glucose Metabolism Disorders, Glucose, High Blood Trial in Bronx (Diazoxide, Placebo)

Active, not recruiting
  • Type 2 Diabetes
  • +2 more
  • Bronx, New York
    Albert Einstein College of Medicine
Nov 11, 2022

Adenine Phosphoribosyltransferase Deficiency, AH Amyloidosis, AHL Amyloidosis Trial in Bristol

Recruiting
  • Adenine Phosphoribosyltransferase Deficiency
  • +83 more
    • Bristol, South West, United Kingdom
      Zoe Plummer
    Sep 26, 2023

    Diabetes and Cognitive Impairment Based on Simultaneous EEG-fMRI

    Recruiting
    • Type 2 Diabetes
    • +2 more
    • Cognitive assessments
    • +3 more
    • Nanjing, Jiangsu, China
      Department of Radiology, the Affiliated Drum Tower Hospital of N
    Oct 23, 2022

    Diabetes, Type 2, Heart Failure Preserved Ejection Fraction Trial in Lumezzane (Evaluation of central and peripheral

    Recruiting
    • Diabetes Mellitus, Type 2
    • Heart Failure Preserved Ejection Fraction
    • Evaluation of central and peripheral neuromuscular fatigue
    • Lumezzane, Brescia, Italy
      Istituti Clinici Scientifici Maugeri IRCCS
    Sep 21, 2023

    Their Correction in Heart and Lung Transplant Recipients and

    Active, not recruiting
    • Endocrine System Diseases
    • +5 more
    • Blood test
    • Budapest, Pest, Hungary
      Heart and Vascular Center
    Jan 7, 2022

    Type2diabetes Trial in Shenzhen (General Practitioners and Diabetes Specialists Co-management)

    Active, not recruiting
    • Type2diabetes
    • General Practitioners and Diabetes Specialists Co-management
    • Shenzhen, Guangdong, China
      Baoan Central Hospital of Shenzhen
    Dec 12, 2022

    Diabetes, Type 2, Hypertension, Cardiovascular Diseases Trial (Integrated Diabetes and Hypertension Primary Care Model,

    Not yet recruiting
    • Diabetes Mellitus, Type 2
    • +2 more
    • Integrated Diabetes and Hypertension Primary Care Model
    • Integrated Diabetes and Hypertension Primary Care Model - Providers
    • (no location specified)
    Oct 6, 2023

    Type 2 Diabetes, Glucose Metabolism Disorders, Glucose, High Blood Trial in Bronx (Diazoxide, Nicotinic acid, Placebo)

    Recruiting
    • Type 2 Diabetes Mellitus
    • +2 more
    • Bronx, New York
      Albert Einstein College of Medicine
    Jun 15, 2022

    Atherosclerosis of Artery, Peripheral Artery Disease, Diabetes Trial in Changsha, Jinan (N-acetylcysteine, Placebo)

    Withdrawn
    • Atherosclerosis of Artery
    • +4 more
    • Changsha, Hunan, China
    • +1 more
    Jun 9, 2023